It’s the holiday season, and for most people that means indulging in seasonal treats and meals. It’s no different for people living with type 1 diabetes (T1D). One of the major stresses of managing T1D, particularly for people who are newly diagnosed can be meal planning, and both how it will affect blood glucose levels […]
The BETTER project is now available across Canada
In November, to celebrate World Diabetes Day, the BETTER (BEhaviors, Therapies, TEchnologies and hypoglycemic Risk in Type 1 diabetes) project announced that it is now the first registry of people living with type 1 diabetes in Canada. A key focus of JDRF’s research strategy is to fund research that can improve the lives of people […]
Kids For A Cure 2022
JDRF’s Kids For a Cure advocacy event was held from November 13- 15 in Ottawa and what an impact our youth delegates made – engaging with more than 55 Members of Parliament and Senators during 20 meetings to share their stories of what it means to live with type 1 diabetes (T1D) and advocate the […]
The Turner family wants to help families like theirs affected by T1D
A diagnosis of type 1 diabetes (T1D) changes the trajectory of an entire family. This was no different for the Turner Family when Alex was diagnosed at 14-years-old. The Turners are a close-knit family, parents Richard and Alison, and children Alex, Sara and Emma approached Alex’s diagnosis together as a family. “At 14 years old, […]
JDRF Centre of Excellence at UBC celebrates 1 year of progress in T1D cure research
December 2021 marked the launch of the JDRF Centre of Excellence at the University of British Columbia (UBC). One year later, a team of over 40 researchers convened in person at UBC for the first annual meeting to review and celebrate progress, translate knowledge, engage with the type 1 diabetes (T1D) community, and discuss what […]
Teplizumab approved for use in people at risk of type 1 diabetes by the US Food and Drug Administration
This is the first therapeutic on the market that may help delay the onset of clinicaltype 1 diabetes November 17, 2022 Today, the U.S. Food and Drug Administration (FDA) weighed the evidence for teplizumab to delay type 1 diabetes (T1D) in at-risk individuals, and the T1D community got a big win: Approved! Teplizumab (Provention Bio […]
The Sun Life Ride to Defeat Diabetes was back in-person and an enormous success!
One of Canada’s longest running and top fundraising events returned to in-person Rides in Montréal and Toronto, on October 6 and 13, 2022 respectively, along with virtual rides across the country. For 35 years Sun Life Ride to Defeat Diabetes for JDRF has been bringing together corporate executives and teams to pedal for a cure for […]
Important update on teplizumab – a therapeutic that may help delay the onset of type 1 diabetes
A key tenet of JDRF’s research funding strategy is that there are multiple pathways to cures for type 1 diabetes (T1D), one of which includes screening for risk and use of therapeutics to delay or even prevent the onset of the disease developing – to give more time to the individual to adapt before requiring […]
JDRF Canada and Stem Cell Network announce the first recipient of the J. Andrew McKee Fellowship in Type 1 Diabetes Blog
Karoliina Tuomela is a postdoctoral researcher at the JDRF Centre of Excellence at the University of British Columbia, and the first recipient of a J. Andrew McKee Fellowship in Type 1 Diabetes (T1D), jointly funded by JDRF Canada and the Stem Cell Network (SCN) based at the JDRF Centre of Excellence at the University of […]
T1D Index
This blog contains content relating to early mortality due to Type 1 Diabetes, which may be confronting and distressing to some readers. Please exercise caution and care when engaging with this content. How many people live with type 1 diabetes (T1D) around the globe? How does T1D affect life expectancy? How many lives could be […]
Honouring Peter Oliver’s life and legacy
September 23, 2022 JDRF is deeply saddened by the loss of an incredible individual who made an unparalleled impact at JDRF, Peter Oliver. “Peter possessed a multitude of qualities that defined him as a leader – visionary, credible, trustworthy, respectful, influential, and empowering are just a few of these traits,” said Dave Prowten, President and CEO […]
Not all sugars are the same: Using glucose to treat hypoglycemia
The following is sponsored content developed in partnership with AMG Medical Low blood glucose—also known as hypoglycemia—can be one of the most challenging, stressful, and often scary parts of living with diabetes. Learning how to treat hypoglycemia is very important. If you live with type 1 diabetes (T1D), you know that being prepared for low […]